Abbott Laboratories will pay $385 million to settle allegations regarding the operation of a manufacturing plant linked to contaminated powdered baby formula, which is suspected of causing infant deaths. The contamination incident led to the temporary closure of the nation's largest formula facility in 2022 and triggered a recall of several infant formula brands, including Similac, which worsened existing supply chain issues.
✓ AI-Debiased Article
4
Wire-neutral
provisional
✓ No loaded language, vague sourcing, or framing detected.
Abbott Laboratories to pay $385 million to settle DOJ lawsuit over baby formula contamination
Abbott Laboratories has agreed to pay $385 million to settle allegations related to its manufacturing plant that produced contaminated baby formula, which is believed to have caused infant deaths. The contamination resulted in the temporary closure of the facility in 2022 and a recall of multiple infant formula brands.
Companies
Abbott Laboratories
Annotating as
No note attached
on this article.
Original vs. Neutral
Original Headline
Abbott agrees to settle DOJ lawsuit over baby formula plant contamination
Neutral Headline
Abbott Laboratories to pay $385 million to settle DOJ lawsuit over baby formula contamination